Companies › HCM

HUTCHMED CHINA LTD (HCM)

Institutional ownership, SEC filings and insider activity

Sector: Healthcare & Pharma · SEC CIK 0001648257 · EDGAR filings · Updated 2026-07-02

HUTCHMED CHINA LTD (HCM) has reported institutional ownership of 0.5%, with 53 institutional managers holding positions valued at $63.9M per the latest 13F reporting period. SEC filings include an active substantial-doubt (going concern) disclosure per the filings.

Latest updates

• 2026-07-02 — Foreign issuer report (6-K) filed
• 2026-06-30 — Foreign issuer report (6-K) filed
• 2026-06-29 — Foreign issuer report (6-K) filed
• 2026-06-25 — Foreign issuer report (6-K) filed
• 2026-06-12 — Foreign issuer report (6-K) filed
• 2026-06-09 — Employee-plan registration (S-8) filed

Institutional ownership overview

According to SEC 13F filings tracked by Sightfile, HUTCHMED CHINA LTD has 53 institutional holders and institutional ownership of 0.5%.

Insider activity

Insiders reported 0 transactions (0 buys, 0 sells) across 8 reporting insiders, with a net reported value of $0.

Data flags from SEC filings

Related companies

LEONABIO INC (LONA) · Unicycive Therapeutics Inc (UNCY) · LIFEMD (LFMD) · Achieve Life Sciences Inc (ACHV) · ALDEYRA THERAPEUTICS INC (ALDX) · Pliant Therapeutics Inc (PLRX)